MedTrace Logo

VOCALE LBD+ for Caregivers of Persons With Lewy Body Dementia

NCT05622734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, and initial efficacy of the VOCALE LBD+ intervention in caregivers of persons living with Lewy Body Dementia. The main question\[s\] it aims to answer are:

* What is the extent to which the VOCALE LBD+ intervention affects caregiving mastery scores at the end of the eight-week intervention
* What is the extent to which a change in caregiving mastery scores is retained four weeks after the end of the VOCALE LBD+ intervention

Participants will be asked to participate in a fully online asynchronous VOCALE LBD+ intervention that involves a moderated web-based discussion platform, peer-to-peer support, didactic training, and problem-solving skill enactment.

Conditions

  • Caregiver Burden
  • Lewy Body Disease
  • Stress
  • Skill, Coping

Interventions

BEHAVIORAL

VOCALE LBD+

Intervention employs a web-based platform that allows participants to engage asynchronously in an eight-week online intervention involving didactic training, peer-to-peer support, and moderated problem-solving skill enactment.

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Washington

    lead OTHER

Principal Investigators

  • Oleg Zaslavsky, PhD · University of Washington

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-21
Primary Completion
2023-11-30
Completion
2023-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622734 on ClinicalTrials.gov